Today, Lancet ran an editorial asking whether Phase 0 trials will become a “platform for drug development.” The editorial responds to the first published ‘phase 0’ study, this June, in Journal of Clinical Oncology (Kummar et al). These studies involve delivering very small quantities of a new drug to test its properties before giving biologically… Continue reading Phased by Phase 0?
Studies of Translation in Ethics and Medicine